Detalhe da pesquisa
1.
Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis.
PLoS Biol
; 20(8): e3001762, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976859
2.
An evolutionarily diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans.
PLoS Biol
; 19(3): e3000957, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720927
3.
The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
PLoS Pathog
; 15(8): e1007460, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381597
4.
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205345
5.
Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818813
6.
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
PLoS Pathog
; 14(5): e1007056, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29746596
7.
Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother
; 64(1)2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685475
8.
APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455236
9.
Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS.
Molecules
; 24(3)2019 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30678308
10.
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
J Antimicrob Chemother
; 72(2): 462-466, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798213
11.
Mucormycosis in 2023: an update on pathogenesis and management.
Front Cell Infect Microbiol
; 13: 1254919, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808914
12.
Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis.
J Fungi (Basel)
; 7(4)2021 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33919611
13.
Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis.
Nat Microbiol
; 6(3): 313-326, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462434
14.
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
mBio
; 11(3)2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487760
15.
NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice.
Sci Rep
; 9(1): 6194, 2019 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996274
16.
Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
mSphere
; 3(5)2018 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381356
17.
Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis.
Front Immunol
; 9: 1349, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29963049
18.
Inhibition of EGFR Signaling Protects from Mucormycosis.
mBio
; 9(4)2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108171